Alpine Global Management, LLC Nuvation Bio Inc. Transaction History

Alpine Global Management, LLC

  • $331 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$2.58 - $3.69 $96,920 - $138,618
37,566 New
37,566 $109,000
Q4 2021

Feb 14, 2022
SELL
$7.75 - $10.05 $499,456 - $647,682
-64,446 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$7.78 - $10.0 $501,389 - $644,460
64,446 New
64,446 $595,000

Others Institutions Holding NUVB

# of Institutions
159
Shares Held
157M
Call Options Held
3.2K
Put Options Held
98.7K
View Full List

About Nuvation Bio Inc.

NUVB Quotes by TradingView
  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $571M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email